Shensong Yangxin capsule in the treatment of mild to moderate systolic heart failure complicated with ventricular Premature beat: A randomize, double-blind, placebo-controlled multicenter trial.

Status: Recruiting

Phase of Trial: Phase IV

Latest Information Update: 18 Sep 2021

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

08 Jan 2013 Biomarkers information updated
07 Jan 2013 Lead trial centre amended as reported by ClinicalTrials.gov.
10 Sep 2012 Planned initiation date changed from 1 Jul 2012 to 1 Mar 2012 as reported by Chinese Clinical Trial Register record.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com